DMID 24-0024 (Avian (H5) Influenza Vaccination) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out if an experimental vaccine is a safe and effective option to protect against H5 avian influenza (bird flu).
What is the Condition Being Studied?
Bird Flu Vaccination in Healthy Volunteers
Who Can Participate in the Study?
Adults ages 18-49 who:
- Are in good general health
- Do not have any form of autoimmune disease
- Do not have regular contact with chickens or cattle
For more information about this study, contact the study team at stephanie.smith@duke.edu.
Grupo etario
Adultos
What is Involved?
Si elige unirse a este estudio, podrá:
- Have a screening visit to confirm your eligibility
- Get 2 doses of the study vaccine about a month apart from each other
- Fill out surveys once a day for 7 days after each vaccination visit
- Visit our clinic up to 5 times for follow-up visits after getting the study vaccine
Study Details
Full Title
A Phase 1 Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Antigenically Central (AC)-Anhui mRNA-LNP Vaccine in Healthy Adults
Principal Investigator
Emmanuel Walter
Protocol Number
IRB:
PRO00117755
Phase
Fase I
Estado de inscripción
Abierto para inscripción